Literature DB >> 17620940

Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.

Marites P Melancon1, Yuetang Wang, Xiaoxia Wen, James A Bankson, L Clifton Stephens, Samar Jasser, Juri G Gelovani, Jeffrey N Myers, Chun Li.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a dual magnetic resonance-near infrared fluorescence optical imaging agent, poly(l-glutamic acid)-DTPA-Gd-NIR813, for both preoperative and intraoperative visualization and characterization of sentinel lymph nodes (SLN) in mice.
MATERIALS AND METHODS: Poly(L-glutamic acid) was conjugated with DTPA-Gd and NIR813 dye to obtain PG-DTPA-Gd-NIR813. To confirm drainage into the SLNs, this agent was injected subcutaneously into the front paw of nude mice followed by isosulfan blue (n = 6). Furthermore, PG-DTPA-Gd-NIR813 was injected subcutaneously at doses of 0.002 mmol Gd/kg (4.8 nmol eq. NIR813) and 0.02 mmol Gd/kg (48 nmol eq. NIR813) (n = 3/dose). To differentiate metastatic from nonmetastatic lymph nodes, nude mice bearing human oral squamous cell carcinoma (DM14) were injected intralingually with 0.02 mmol Gd/kg PG-DTPA-Gd-NIR813 (n = 3). Pre- and postcontrast images were taken using 4.7 T Bruker MRI scanner and Xenogen optical imaging system. The status of lymph nodes resected under the guidance of optical imaging was confirmed by histologic examinations.
RESULTS: PG-DTPA-Gd-NIR813 colocalized with isosulfan blue, indicating drainage to the SLN. After subcutaneous injection, axiliary and branchial lymph nodes were clearly visualized with both T1-weighted MR and optical imaging within 3 minutes of contrast injection, even at the lowest dose tested (0.002 mmol Gd/kg). After intralingual injection in tumor-bearing mice, MR imaging identified 4 of the 6 superficial cervical lymph nodes, whereas near-infrared fluorescence (NIRF) optical imaging identified all 6 cervical nodes. The pattern of contrast enhancement of SLN visualized in MR images showed a characteristic ring-shaped appearance with a central filling defect, possibly resulting from nodal infiltration of metastatic lesions. Histopathologic examination of the SLNs resected under NIRF imaging guidance revealed micrometastases in all 6 SLNs identified by NIRF imaging.
CONCLUSIONS: The dual modality imaging method demonstrated in this study represents an effective technique for localization and characterization of SLN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620940      PMCID: PMC2746745          DOI: 10.1097/RLI.0b013e31804f5a79

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  22 in total

1.  Interstitial MR lymphangiography for the detection of sentinel lymph nodes.

Authors:  M G Torchia; R Nason; R Danzinger; J M Lewis; J A Thliveris
Journal:  J Surg Oncol       Date:  2001-11       Impact factor: 3.454

2.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping.

Authors:  Sungjee Kim; Yong Taik Lim; Edward G Soltesz; Alec M De Grand; Jaihyoung Lee; Akira Nakayama; J Anthony Parker; Tomislav Mihaljevic; Rita G Laurence; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni
Journal:  Nat Biotechnol       Date:  2003-12-07       Impact factor: 54.908

3.  A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma.

Authors:  Susan A Eicher; Gary L Clayman; Jeffrey N Myers; Ann M Gillenwater
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-03

4.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.

Authors:  Moritz F Kircher; Umar Mahmood; Raymond S King; Ralph Weissleder; Lee Josephson
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

5.  MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.

Authors:  L Harika; R Weissleder; K Poss; C Zimmer; M I Papisov; T J Brady
Journal:  Magn Reson Med       Date:  1995-01       Impact factor: 4.668

6.  Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.

Authors:  Philippe Bourrinet; Howard H Bengele; Bruno Bonnemain; Anne Dencausse; Jean-Marc Idee; Paula M Jacobs; Jerome M Lewis
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

7.  Sentinel lymph node mapping of the gastrointestinal tract by using invisible light.

Authors:  Edward G Soltesz; Sungjee Kim; Sang-Wook Kim; Rita G Laurence; Alec M De Grand; Cherie P Parungo; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni
Journal:  Ann Surg Oncol       Date:  2006-01-31       Impact factor: 5.344

Review 8.  Sentinel lymph node in breast cancer.

Authors:  Ted A James; Stephen B Edge
Journal:  Curr Opin Obstet Gynecol       Date:  2006-02       Impact factor: 1.927

9.  Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Yoshio Sakai; Peter L Choyke; Robert A Star; Martin W Brechbiel; Noriko Sato; Yutaka Tagaya; John C Morris; Thomas A Waldmann
Journal:  J Natl Cancer Inst       Date:  2004-05-05       Impact factor: 13.506

10.  Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

Authors:  Eyk A Schellenberger; Alexei Bogdanov; Dagmar Högemann; Jonathan Tait; Ralph Weissleder; Lee Josephson
Journal:  Mol Imaging       Date:  2002 Apr-Jun       Impact factor: 4.488

View more
  19 in total

1.  Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813.

Authors:  Marites P Melancon; Wei Lu; Qian Huang; Prakash Thapa; Dapeng Zhou; Chaan Ng; Chun Li
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

Review 2.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties.

Authors:  Jelena M Janjic; Pin Shao; Shaojuan Zhang; Xun Yang; Sravan K Patel; Mingfeng Bai
Journal:  Biomaterials       Date:  2014-03-25       Impact factor: 12.479

Review 4.  Sentinel lymph node biopsy in renal malignancy: The past, present and future.

Authors:  Tharani Mahesan; Alberto Coscione; Ben Ayres; Nick Watkin
Journal:  World J Nephrol       Date:  2016-03-06

5.  Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery.

Authors:  Marites P Melancon; Andrew M Elliott; Anil Shetty; Qian Huang; R Jason Stafford; Chun Li
Journal:  J Control Release       Date:  2011-07-02       Impact factor: 9.776

Review 6.  Animal models and molecular imaging tools to investigate lymph node metastases.

Authors:  Elliot L Servais; Christos Colovos; Adam J Bograd; Julie White; Michel Sadelain; Prasad S Adusumilli
Journal:  J Mol Med (Berl)       Date:  2011-05-10       Impact factor: 4.599

7.  High resolution MRI for non-invasive mouse lymph node mapping.

Authors:  Zhuoli Zhang; Daniel Procissi; Weiguo Li; Dong-Hyun Kim; Kangan Li; Guohong Han; Yi Huan; Andrew C Larson
Journal:  J Immunol Methods       Date:  2013-07-12       Impact factor: 2.303

8.  A nanocomposite of Au-AgI core/shell dimer as a dual-modality contrast agent for x-ray computed tomography and photoacoustic imaging.

Authors:  Anamaria Orza; Yi Yang; Ting Feng; Xueding Wang; Hui Wu; Yuancheng Li; Lily Yang; Xiangyang Tang; Hui Mao
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

9.  Rab25 regulates invasion and metastasis in head and neck cancer.

Authors:  Panomwat Amornphimoltham; Kamil Rechache; Jamie Thompson; Andrius Masedunskas; Kantima Leelahavanichkul; Vyomesh Patel; Alfredo Molinolo; J Silvio Gutkind; Roberto Weigert
Journal:  Clin Cancer Res       Date:  2013-01-22       Impact factor: 12.531

10.  Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow.

Authors:  Alanna Ruddell; Maria I Harrell; Satoshi Minoshima; Kenneth R Maravilla; Brian M Iritani; Steven W White; Savannah C Partridge
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.